MedSci Healthcare Holdings Ltd. has published its 2024 Annual Report, presenting key business updates and financial performance. The report highlights the company's strategic focus on compliance-based development, academization, and digitalization in response to significant changes in China's medical healthcare industry. The Chairman, Dr. Zhang Fabao, emphasized the company's commitment to evidence-based medicine and innovation as drivers of value creation. The financial summary includes results and assets and liabilities for the past five financial years. The full report can be accessed through the link below.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。